Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CASU, Benito")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 44

  • Page / 2
Export

Selection :

  • and

Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycansCASU, Benito; NAGGI, Annamaria; TORRI, Giangiacomo et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 335-342, issn 0094-6176Article

New anticoagulantsHARENBERG, Job; CASU, Benito.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, issn 0094-6176, 116 p.Conference Proceedings

Glycosaminoglycans: Anticoagulant and Nonanticoagulant ActionsHARENBERG, Job; CASU, Benito.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, issn 0094-6176, 82 p.Serial Issue

Structural and conformational aspects of the anticoagulant and antithrombotic activity of heparin and dermatan sulfate : Heparin and heparinoids: Correlation between structure and antithrombotic activity. Clinical applications and future perspectivesCASU, Benito; GUERRINI, Marco; TORRI, Giangiacomo et al.Current pharmaceutical design. 2004, Vol 10, Num 9, pp 939-949, issn 1381-6128, 11 p.Article

Heparin, low molecular weight heparin, and derivatives in thrombosis, angiogenesis, and inflammation : Emerging linksMOUSA, Shaker A.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 524-533, issn 0094-6176, 10 p.Conference Paper

Antimetastatic activities of modified heparins : Selectin inhibition by heparin attenuates metastasisBORSIG, Lubor.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 540-546, issn 0094-6176, 7 p.Conference Paper

High-performance liquid chromatographic/ mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanaseBISIO, Antonella; MANTEGAZZA, Alessandra; URSO, Elena et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 488-495, issn 0094-6176, 8 p.Conference Paper

Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solutionHRICOVINI, Milos; GUERRINI, Marco; BISIO, Antonella et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 325-334, issn 0094-6176Article

Low-molecular-weight heparin and dermatan sulfate end group-labeled with tyramine and fluorescein. Biochemical and biological characterization of the fluorescent-labeled heparin derivativeHARENBERG, Job; CASU, Benito; GUERRINI, Marco et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 343-354, issn 0094-6176Article

Monitoring of anticoagulant effects of direct thrombin inhibitorsFENYVESI, Tivadar; JÖRG, Ingrid; HARENBERG, Job et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 361-368, issn 0094-6176Article

Detection of the low molecular weight heparin component of ITF 1300 in urines after intranasal administration to dogsORESTE, P; STELLA, P; ZOPPETTI, G et al.Seminars in thrombosis and hemostasis. 1994, Vol 20, Num 3, pp 293-296, issn 0094-6176Conference Paper

Heparanase : Structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfateVLODAVSKY, Israel; ILAN, Neta; NAGGI, Annamaria et al.Current pharmaceutical design. 2007, Vol 13, Num 20, pp 2057-2073, issn 1381-6128, 17 p.Article

The Tainted Heparin Story: An UpdateGUERRINI, Marco; SHRIVER, Zachary; BISIO, Antonella et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 907-911, issn 0340-6245, 5 p.Conference Paper

Plasma thrombin neutralization assay : pharmacokinetic applicationsIORIO, A; ALATRI, A; MAZZOLAI, L et al.Seminars in thrombosis and hemostasis. 1994, Vol 20, Num 3, pp 266-273, issn 0094-6176Conference Paper

Affinity and kinetics of different heparins binding to P-and L-selectinSIMONIS, Dirk; CHRIST, Katrin; ALBAN, Susanne et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 534-539, issn 0094-6176, 6 p.Conference Paper

Effects of calcium ions on the interactions between antithrombin and factor Xa mediated by variously sulfated, semisynthetic low-molecular-weight heparinsSISSI, Claudia; LUCATELLO, Lorena; NAGGI, Annamaria et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 355-359, issn 0094-6176Article

Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis modelHARENBERG, Job; ZOKAI, Kawei; PIAZOLO, Lukas et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 379-382, issn 0094-6176Article

Low molecular weight heparins : Structural differentiation by bidimensional nuclear magnetic resonance spectroscopyGUERRINI, Marco; GUGLIERI, Sara; NAGGI, Annamaria et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 478-487, issn 0094-6176, 10 p.Conference Paper

Pharmacokinetic and pharmacodynamic characterization of a medium-molecular-weight heparin in comparison with UFH and LMWHALBAN, Susanne; WELZEL, Dieter; HEMKER, H. Coenraad et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 369-377, issn 0094-6176Article

Competitive binding of low molecular mass heparin-tyramine fluorescein-5-isothiocyanate and unlabeled glycosaminoglycans to leukocytesHARENBERG, J; MALSCH, R; PIAZOLO, L et al.Seminars in thrombosis and hemostasis. 1994, Vol 20, Num 3, pp 236-244, issn 0094-6176Conference Paper

Pharmacological activity of a low molecular weight dermatan sulfate (Desm:in) in healthy volunteersDETTORI, A. G; GALLI, G; MANOTTI, C et al.Seminars in thrombosis and hemostasis. 1994, Vol 20, Num 3, pp 259-265, issn 0094-6176Conference Paper

The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivativesSCHLESINGER, Martin; SCHMITZ, Patrick; ZEISIG, Reiner et al.Thrombosis research. 2012, Vol 129, Num 5, pp 603-610, issn 0049-3848, 8 p.Article

Measurement of maximum thrombin generation capacity in blood and plasma using the thrombin generation assay (THROGA)NOWAK, Götz; LANGE, Ute; WIESENBURG, Annett et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 508-514, issn 0094-6176, 7 p.Conference Paper

Preclinical and clinical characteristics of rivaroxaban : A novel, oral, direct factor xa inhibitorLAUX, Volker; PERZBORN, Elisabeth; KUBITZA, Dagmar et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 515-523, issn 0094-6176, 9 p.Conference Paper

Variability of heparins and heterogeneity of low molecular weight heparinsBIANCHINI, Pietro; LIVERANI, Lino; SPELTA, Franco et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 496-502, issn 0094-6176, 7 p.Conference Paper

  • Page / 2